SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-032786
Filing Date
2021-06-14
Accepted
2021-06-14 16:23:00
Documents
13
Period of Report
2021-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 2021 AGM alks-8k_20210614.htm   iXBRL 8-K 55643
2 EX-10.1 alks-ex101_15.htm EX-10.1 121829
  Complete submission text file 0001564590-21-032786.txt   333898

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alks-20210614.xsd EX-101.SCH 5776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alks-20210614_lab.xml EX-101.LAB 19413
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alks-20210614_pre.xml EX-101.PRE 11606
6 EXTRACTED XBRL INSTANCE DOCUMENT alks-8k_20210614_htm.xml XML 3531
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 211014860
SIC: 2834 Pharmaceutical Preparations